Company Overview Alnylam was founded in 2002 on a revolutionary vision and bold mission which remain firmly in place today. We are leading the translation of RNAi as a new class of medicines with a core focus on RNAi therapeutics toward genetically defined targets for the treatment of serious, life-threatening diseases with limited treatment options for patients and their caregivers. In January 2015, we announced our “Alnylam 2020” guidance that reflects our expected transition from a late-stage clinical development company to a multi-product commercial-stage company with a sustainable development pipeline. Alnylam is proud to have been recognized as one of The Boston Globe’s Top Places to Work in 2015, 2016 and 2017. Program DetailsWith RNAi technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way. Alnylam Summer Internships are designed to develop practical biotech industry knowledge and soft skill advancement, while contributing to the company’s overall mission and goals. As Alnylam heads towards commercialization, there are a number of departments with meaningful internships available that balance professional development and support organizational needs during this exciting transition. Interns will also participate in companywide functions such as Annual Community Service Day, Summer Outing, as well as events & development programs designed exclusively for students. Applicants will be directed to choose from the following internships by area of interest: Research, Finance, Commercial & Marketing, Medical Affairs, Quality Assurance, Manufacturing, Legal, Corporate Communications, Supply Chain, IT, Clinical Development & Clinical Operations. Qualifications· You must be legally eligible to work in the U.S· The target start date is May 29 with an expected end date of mid/late August· Must be currently enrolled in a Bachelors, Masters or PhD program (varies by area) Summer Intern Position in Clinical Pharmacology and Pharmacometrics Job Description:Through this program, intern will gain experiencein utility of quantitative methods in supporting RNAi therapeutics fordrug development of orphan disease indications. The students may interact withclinicians, biometrics, research, DMPK, or clinical pharmacology scientists.Depending on the interests of the interns following projects may be assigned· Compartmental and PBPK modeling of RNAitherapeutics· Exposure-response modeling· Systems pharmacology modeling of disease usingliterature and in-house data· Statistical modeling of endpoints informing trialoperating characteristics Requirements:Currently enrolled in a PharmD, or MS/PhD degree program inPharmacometrics, Pharmaceutical Sciences, Bioengineering, AppliedMathematics/Statistics, or a related field. Eligible to work on a full-timebasis during the internship duration. Proficiency with quantitativesoftware e.g. Phoenix, R, and NONMEM Strong understanding of fundamentals of PKPD and hierarchicalmodeling of continuous and non-continuous endpoints. Exposure to Bayesianapproaches is highly desirable.Visit the following link to apply Alnylam Summer Internship Program 2018 | | | Alnylam Summer Internship Program 2018 Click the link provided to see the complete job description. | |
|
